0.1533
price down icon3.71%   -0.0059
 
loading

BETTERLIFE PHARMA INC Stock (BETRF) Forecast

The BETTERLIFE PHARMA INC (BETRF) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.1631, representing a +6.40% increase from the current price of $0.1533. The highest analyst price target is $0.1728, and the lowest is $0.1535.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BETRF Price Target
Average 0.3687 (+140.51% Upside)
loading

Is BETTERLIFE PHARMA INC (BETRF) A Buy Now?

Oscillators
Name Value Action
RSI(14) 34.75 Neutral
STOCH(9,6) 11.12 Buy
STOCHRSI(14) 6.7156 Buy
MACD(12,26) -0.0181 Sell
ADX(14) 12.64 Neutral
William %R -99.27 Buy
CCI(14) -66.84 Neutral
Buy: 3 Sell: 1 Neutral: 3
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
0.1742
Sell
0.1735
Sell
MA20
0.1973
Sell
0.1899
Sell
MA50
0.2182
Sell
0.1984
Sell
MA100
0.1696
Sell
0.1734
Sell
MA200
0.1067
Buy
0.1152
Buy
Buy: 2 Sell: 8 Neutral: 0
Summary: Sell
According to our latest analysis, BETRF could be considered a Strong Sell, with 17 technical analysis indicators signaling 5 Buy signals, 9 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on BETRF, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 34.75 indicates that BETRF is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 11.12 indicates that BETRF is oversold. This indicates that BETRF price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 6.7156 indicates that BETRF is oversold. This suggests that BETRF price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 12.64 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -66.84 indicates that BETRF is still oversold but not to an extreme extent.

Long-term BETRF price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about BETTERLIFE PHARMA INC financial reports and earnings history, BETTERLIFE PHARMA INC (BETRF) stock could reach $0.8627 by 2030, $3.3713 by 2040 and $3.1787 by 2050. See the projected annual prices until 2050 of the BETTERLIFE PHARMA INC stock below:

  • BETTERLIFE PHARMA INC (BETRF) is expected to reach an average price of $2.0688 in 2035, with a high prediction of $2.1118 and a low estimate of $1.9747. This indicates an $1,250% rise from the last recorded price of $0.1533.
  • BETTERLIFE PHARMA INC (BETRF) stock is projected to chart a bullish course in 2040, with an average price target of $1.2922, representing an $742.92% surge from its current level. The forecast ranges from a conservative $1.2913 to a sky-high $3.3713.
  • Our analysts predict BETTERLIFE PHARMA INC (BETRF) to jump 1,282% by 2045, soaring from $1.9289 to an average price of $2.1185, potentially reaching $2.1298. While $1.9289 is the low estimate, the potential upside is significant.
  • BETTERLIFE PHARMA INC (BETRF) stock is expected to climb by 2050, reaching an average of $3.1787, a $1,974% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.1787 and $2.9278, respectively, highlighting the market's uncertainty.

BETTERLIFE PHARMA INC Stock (BETRF) Year by Year Forecast

BETTERLIFE PHARMA INC Stock (BETRF) Price Forecast for 2026

The predicted value for BETTERLIFE PHARMA INC (BETRF) in 2026 is set at an average of $0.1798. Estimates vary from a peak of $0.3311 to a trough of $0.0285, indicating an +17.29% surge from the present price of $0.1533.
Month Average Low High Change from today's price
November, 2026 $0.166 $0.1535 $0.1728 +8.27%
December, 2026 $0.1785 $0.1605 $0.1803 +16.45%

BETTERLIFE PHARMA INC Stock (BETRF) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for BETTERLIFE PHARMA INC (BETRF) is $0.3752, with a high forecast of $0.5839 and a low forecast of $0.1665. This indicates an +144.74% increase from the last price of $0.1533.
Month Average Low High Change from today's price
January, 2027 $0.1759 $0.1665 $0.1943 +14.77%
February, 2027 $0.1969 $0.1755 $0.1969 +28.46%
March, 2027 $0.2103 $0.1925 $0.2181 +37.19%
April, 2027 $0.2305 $0.2147 $0.2478 +50.36%
May, 2027 $0.2509 $0.2324 $0.2511 +63.66%
June, 2027 $0.2563 $0.2484 $0.2658 +67.17%
July, 2027 $0.2655 $0.257 $0.2707 +73.16%
August, 2027 $0.3683 $0.2671 $0.387 +140.27%
September, 2027 $0.4582 $0.3598 $0.4615 +198.91%
October, 2027 $0.4993 $0.4478 $0.5839 +225.71%
November, 2027 $0.5168 $0.4691 $0.5659 +237.11%
December, 2027 $0.448 $0.4434 $0.5207 +192.22%

BETTERLIFE PHARMA INC Stock (BETRF) Price Forecast for 2028

In 2028, BETTERLIFE PHARMA INC (BETRF) is projected to reach an average price of $0.549, with a high projection of $0.8367 and a low estimate of $0.2613. This indicates an +258.13% rise from the last price of $0.1533.
Month Average Low High Change from today's price
January, 2028 $0.2685 $0.2613 $0.283 +75.13%
February, 2028 $0.2974 $0.2771 $0.2989 +94.03%
March, 2028 $0.3155 $0.2904 $0.3302 +105.81%
April, 2028 $0.3304 $0.3116 $0.3387 +115.51%
May, 2028 $0.3745 $0.3434 $0.3759 +144.32%
June, 2028 $0.4189 $0.3779 $0.4189 +173.27%
July, 2028 $0.4324 $0.4116 $0.4364 +182.05%
August, 2028 $0.4579 $0.4326 $0.4677 +198.69%
September, 2028 $0.4793 $0.4588 $0.4847 +212.65%
October, 2028 $0.5749 $0.4827 $0.5789 +275.01%
November, 2028 $0.6487 $0.5681 $0.6577 +323.13%
December, 2028 $0.7149 $0.6304 $0.8367 +366.36%

BETTERLIFE PHARMA INC Stock (BETRF) Price Forecast for 2029

The 2029 price forecast for BETTERLIFE PHARMA INC Stock (BETRF) is $0.602 on average, with a high prediction of $0.8397 and a low estimate of $0.3643. This represents an +292.69% increase from the previous price of $0.1533.
Month Average Low High Change from today's price
January, 2029 $0.7716 $0.71 $0.7936 +403.32%
February, 2029 $0.7563 $0.7531 $0.8397 +393.34%
March, 2029 $0.3733 $0.3643 $0.7916 +143.50%
April, 2029 $0.4079 $0.377 $0.4129 +166.10%
May, 2029 $0.4445 $0.4166 $0.4445 +189.92%
June, 2029 $0.4658 $0.4384 $0.4763 +203.88%
July, 2029 $0.5148 $0.4714 $0.5218 +235.81%
August, 2029 $0.5542 $0.5214 $0.5588 +261.48%
September, 2029 $0.5983 $0.5645 $0.6156 +290.29%
October, 2029 $0.6487 $0.6062 $0.6487 +323.13%
November, 2029 $0.678 $0.6522 $0.6846 +342.28%
December, 2029 $0.7258 $0.6847 $0.7279 +373.46%

BETTERLIFE PHARMA INC Stock (BETRF) Price Forecast for 2030

BETTERLIFE PHARMA INC Stock (BETRF) is expected to reach an average price of $0.7904 in 2030, with a high forecast of $1.1135 and a low forecast of $0.4673. This signifies an +415.58% surge from the last price of $0.1533.
Month Average Low High Change from today's price
January, 2030 $0.844 $0.7277 $0.8627 +450.56%
February, 2030 $0.9579 $0.8415 $0.9612 +524.83%
March, 2030 $1.0229 $0.9594 $1.0896 +567.27%
April, 2030 $1.0704 $1.0047 $1.1135 +598.22%
May, 2030 $1.0255 $1.0209 $1.0803 +568.97%
June, 2030 $0.492 $0.4673 $0.5033 +220.91%
July, 2030 $0.5514 $0.4984 $0.5529 +259.68%
August, 2030 $0.5934 $0.5504 $0.6021 +287.10%
September, 2030 $0.6513 $0.5955 $0.6574 +324.82%
October, 2030 $0.7064 $0.6594 $0.7078 +360.79%
November, 2030 $0.7747 $0.7158 $0.7747 +405.37%
December, 2030 $0.8182 $0.7734 $0.8213 +433.70%
Cap:     |  Volume (24h):